← All published screens
Highest ROE in Healthcare
Snapshot from 2026-07-31 · 25 stocks
Sector is Healthcare
| Ticker | Name | Sector | Price | Market Cap | P/E | P/B | ROE | Gross Margin |
|---|---|---|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics, Inc. - Common Stock | Healthcare | $83.30 | $9.88B | 31.18 | 44.99 | 144.3% | — |
| AVAH | Aveanna Healthcare Holdings Inc. - Common Stock | Healthcare | $9.69 | $2.11B | 9.38 | 8.79 | 93.7% | — |
| AUPH | Aurinia Pharmaceuticals Inc - Common Shares | Healthcare | $15.00 | $1.93B | 6.72 | 3.40 | 50.6% | — |
| EXEL | Exelixis, Inc. - Common Stock | Healthcare | $55.97 | $14.07B | 17.98 | 7.27 | 40.4% | — |
| MRK | Merck & Company, Inc. Common Stock (new) | Healthcare | $129.79 | $320.56B | 17.56 | 6.99 | 39.8% | — |
| ALNY | Alnylam Pharmaceuticals, Inc. - Common Stock | Healthcare | $205.48 | $27.25B | 86.86 | 34.53 | 39.8% | — |
| TMDX | TransMedics Group, Inc. - Common Stock | Healthcare | $76.13 | $2.63B | 13.83 | 5.33 | 38.5% | — |
| CRMD | CorMedix Inc. - Common Stock | Healthcare | $7.49 | $587.60M | 3.60 | 1.34 | 37.3% | — |
| TBPH | Theravance Biopharma Inc | Healthcare | $16.85 | $868.67M | 8.20 | 2.99 | 36.4% | — |
| GILD | Gilead Sciences, Inc. - Common Stock | Healthcare | $131.28 | $162.99B | 19.15 | 6.93 | 36.2% | — |
| BMY | Bristol-Myers Squibb Company Common Stock | Healthcare | $64.86 | $132.45B | 18.78 | 6.60 | 35.2% | — |
| JNJ | Johnson & Johnson | Healthcare | $255.82 | $615.81B | 22.97 | 7.59 | 33.0% | — |
| CHE | Chemed Corp | Healthcare | $534.79 | $7.10B | 26.76 | 8.37 | 31.3% | — |
| NVS | Novartis AG Common Stock | Healthcare | $158.44 | $302.33B | 21.62 | 6.55 | 30.3% | — |
| DXCM | DexCom, Inc. - Common Stock | Healthcare | $74.54 | $28.76B | 34.39 | 9.73 | 28.3% | — |
| IRMD | iRadimed Corporation - Common Stock | Healthcare | $95.21 | $1.22B | 54.14 | 12.35 | 22.8% | — |
| UTHR | United Therapeutics Corporation - Common Stock | Healthcare | $525.82 | $22.32B | 16.72 | 3.78 | 22.6% | — |
| EHC | Encompass Health Corporation Common Stock | Healthcare | $110.89 | $11.00B | 19.43 | 4.36 | 22.5% | — |
| RMD | ResMed Inc. Common Stock | Healthcare | $208.56 | $30.25B | 21.60 | 4.66 | 21.6% | — |
| CPRX | Catalyst Pharmaceuticals, Inc. - Common Stock | Healthcare | $31.49 | $3.85B | 17.98 | 3.81 | 21.2% | — |
| OGN | Organon & Co. Common Stock | Healthcare | $13.55 | $3.56B | 19.03 | 3.94 | 20.7% | — |
| MSA | MSA Safety Incorporated Common Stock | Healthcare | $174.35 | $6.73B | 24.13 | 4.97 | 20.6% | — |
| VRTX | Vertex Pharmaceuticals Incorporated - Common Stock | Healthcare | $481.70 | $122.26B | 30.93 | 6.31 | 20.4% | — |
| INVA | Innoviva, Inc. - Common Stock | Healthcare | $21.22 | $1.57B | 5.78 | 1.17 | 20.2% | — |
| COLL | Collegium Pharmaceutical, Inc. - Common Stock | Healthcare | $35.98 | $1.17B | 18.56 | 3.74 | 20.1% | — |